ICD Future Growth

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ICD has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A040910 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	62,274	-37,407	-7,636	-1,465	N/A
9/30/2023	76,827	-39,569	-30,828	-21,947	N/A
6/30/2023	110,543	-25,056	-17,023	-7,278	N/A
3/31/2023	149,043	-13,433	-18,948	-8,966	N/A
12/31/2022	150,945	-5,419	-23,621	-14,294	N/A
9/30/2022	136,063	6,018	-9,696	-2,454	N/A
6/30/2022	106,205	1,751	-12,820	-7,534	N/A
3/31/2022	103,384	-4,692	-17,521	-14,162	N/A
12/31/2021	115,769	762	16,680	21,230	N/A
9/30/2021	152,326	-3,387	35,006	39,655	N/A
6/30/2021	256,824	17,001	65,585	69,605	N/A
3/31/2021	286,426	28,303	67,603	71,527	N/A
12/31/2020	308,965	33,459	46,525	49,530	N/A
9/30/2020	297,368	46,448	16,513	19,177	N/A
6/30/2020	195,693	31,912	-11,974	-10,056	N/A
3/31/2020	133,702	17,397	1,538	3,688	N/A
12/31/2019	121,605	11,152	20,705	23,966	N/A
9/30/2019	136,119	18,890	38,252	43,434	N/A
6/30/2019	149,368	14,340	28,894	33,972	N/A
3/31/2019	194,565	16,102	37,096	46,625	N/A
12/31/2018	233,975	29,834	25,477	29,835	N/A
9/30/2018	285,285	26,393	-3,783	-3,079	N/A
6/30/2018	324,863	30,425	10,616	14,616	N/A
3/31/2018	267,977	31,296	-10,264	-10,007	N/A
12/31/2017	311,848	24,491	-16,613	-11,884	N/A
9/30/2017	272,220	16,792	N/A	2,109	N/A
6/30/2017	272,686	17,245	N/A	-4,378	N/A
3/31/2017	328,387	18,684	N/A	-14,771	N/A
12/31/2016	230,909	10,354	N/A	-9,108	N/A
12/31/2015	72,061	5,413	N/A	8,817	N/A
9/30/2013	81,040	7,220	N/A	32,001	N/A
6/30/2013	47,289	2,902	N/A	34,138	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A040910's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if A040910's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A040910's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A040910's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A040910's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A040910's Return on Equity is forecast to be high in 3 years time

ICD Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target lowered to ₩22,500

Recent updates

ICD Co., Ltd. announced that it has received KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Kiwoomfni Co., Ltd., Shinhan Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd.

ICD Co., Ltd. announced that it expects to receive KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Kiwoomfni Co., Ltd., Shinhan Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd.

ICD Co., Ltd.'s (KOSDAQ:040910) 47% Price Boost Is Out Of Tune With Revenues

New minor risk - Share price stability

New minor risk - Market cap size

Upcoming dividend of ₩100.00 per share at 1.1% yield

New minor risk - Shareholder dilution

New major risk - Dividend sustainability

Investor sentiment improves as stock rises 20%

Investor sentiment improves as stock rises 18%

Upcoming dividend of ₩200 per share

No independent directors

ICD Co., Ltd. (KOSDAQ:A040910) announces an Equity Buyback for KRW 3,000 million worth of its shares.

No independent directors

Upcoming dividend of ₩350 per share

ICD Co., Ltd. announced that it has received KRW 18000 billion in funding from Eugene Investment & Securities Co.,Ltd.

First quarter 2021 earnings released: EPS ₩131 (vs ₩446 in 1Q 2020)

The Attractive Combination That Could Earn ICD Co., Ltd. (KOSDAQ:040910) A Place In Your Dividend Portfolio

ICD (KOSDAQ:040910) Could Easily Take On More Debt

New 90-day low: ₩15,750

When Should You Buy ICD Co., Ltd. (KOSDAQ:040910)?

Price target lowered to ₩22,500

ICD Co., Ltd., Annual General Meeting, Mar 26, 2021

If You Like EPS Growth Then Check Out ICD (KOSDAQ:040910) Before It's Too Late

Are Robust Financials Driving The Recent Rally In ICD Co., Ltd.'s (KOSDAQ:040910) Stock?

Under The Bonnet, ICD's (KOSDAQ:040910) Returns Look Impressive

Is ICD Co., Ltd. (KOSDAQ:040910) An Attractive Dividend Stock?

Be Sure To Check Out ICD Co., Ltd. (KOSDAQ:040910) Before It Goes Ex-Dividend

Upcoming Dividend of ₩150 Per Share

New 90-day high: ₩17,550

Is ICD's (KOSDAQ:040910) Share Price Gain Of 142% Well Earned?

We Think ICD (KOSDAQ:040910) Can Manage Its Debt With Ease

Third quarter 2020 earnings released: EPS ₩1,265

New 90-day low: ₩14,200

New 90-day high - ₩17,400

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies